NEW YORK, Aug. 24, 2015 /PRNewswire/ -- IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.
The global IVF market is expected to reach $11.3 billion by 2021, at a CAGR of 7.0% from 2015 to 2021. Reduction in conception rates mainly in women aged 40 years or above, delayed pregnancy in women suffering from gynecological conditions, changing lifestyle and fertility disorders are the major factors that drive the market growth. Other factors responsible for the market growth are favorable reimbursement scenario and the delayed parenthood opted by couples due to professional and financial constraints. On the other hand, ethical concerns in particular countries, high cost of the IVF procedures and low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.
The rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.
To provide a detailed market assessment, the report segments the global IVF market on the basis of end-users and geography. The end-users IVF market is categorized into fertility clinics, hospitals, surgical centres and clinical research institutes. Fertility clinics and hospitals were the leading end-user segments globally, accounting for around three-fourths of the market in 2014.
Geographically, the market is segmented across North America, Europe, Asia Pacific and LAMEA regions. In terms of number of IVF cycles performed, the Asia-Pacific region dominates the global IVF market. Asia Pacific IVF market is set to grow at a promising CAGR of 8.9% from 2015 to 2021, due to the factors such as wide availability of IVF clinics, high IVF success rates and the rising trend of fertility tourism. In Asia-Pacific region, China is the leading country accounting for majority of the market share and is expected to maintain its position during the analysis period. In terms of revenue, North America dominates the global IVF market, owing to the favorable reimbursement scenario. The market is expected to reach around $4.0 billion by 2021, at a CAGR of 7.9% over the forecast period.
KEY MARKET BENEFITS:
The report provides an in-depth analysis of the IVF market across twenty major countries with a cross sectional analysis of the number of IVF cycles performed, and total revenue generated during the forecast period
The report helps in understanding the strategies adopted by various IVF clinics and hospitals in particular countries, in order to gain market share in the global IVF service market
Region-wise and country-wise IVF market is comprehensively analyzed in the report
The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2014–2021, in terms of value and volume
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
KEY MARKET SEGMENTS:
The global IVF market is segmented on the basis of end-users and geography:
Global IVF Market – By End Users (Value and Volume)
Clinical research institutes
Global IVF Market – By End User Country Level Analysis (Value and Volume)
Global IVF Market – By Geography (Value and Volume)
Read the full report: http://www.reportlinker.com/p03101185-summary/view-report.html
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001